NCT05243160View on ClinicalTrials.gov

Medication Reviews in Severe Mental Illness

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 11, 2022

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2023

Conditions
SchizophreniaDiabetesMetabolic SyndromeSevere Mental DisorderMajor Depressive DisorderBipolar DisorderPsychosisPsychotic Disorders
Interventions
OTHER

medication review

The intervention consist of a medication review by a clinical pharmacologist.

Trial Locations (1)

4200

Research Unit for Psychotherapy and Psychopathology, Slagelse

All Listed Sponsors
collaborator

Steno Diabetes Center Sjaelland

OTHER_GOV

collaborator

Region Zealand

OTHER

lead

Psychiatric Research Unit, Region Zealand, Denmark

OTHER